Literature DB >> 18452882

Potassium channels in atrial fibrillation: targets for atrial and pathology-specific therapy?

Ursula Ravens1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18452882     DOI： 10.1016/j.hrthm.2007.11.008

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  6 in total

Review 1.  New developments in atrial antiarrhythmic drug therapy.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Nat Rev Cardiol       Date:  2010-03       Impact factor: 32.419

Review 2.  Novel pharmacological targets for the rhythm control management of atrial fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pharmacol Ther       Date:  2011-08-17       Impact factor: 12.310

3.  Advances in the Pharmacologic Management of Atrial Fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Card Electrophysiol Clin       Date:  2011-03

4.  Advances in the Pharmacological Treatment of Atrial Fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Curr Med Lit Cardiol       Date:  2010-01-01

Review 5.  Ion channel trafficking: a new therapeutic horizon for atrial fibrillation.

Authors:  Sarah M Schumacher; Jeffrey R Martens
Journal:  Heart Rhythm       Date:  2010-02-13       Impact factor: 6.343

Review 6.  New pharmacological strategies for the treatment of atrial fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.